Current Projects
 
Search
 

Home
Search for Projects
View Projects
Project Title
by Subject/Focus Area
by Board/Committee
by Major Unit
Provisional Committee Appointments Open for Formal Public Comments
by Last Update
Meeting Information
Conflict of Interest Policy
Committee Appointment Process
FAQ
  Project Information

Project Information

 Printer Friendly Version

Project Title:

Cancer Clinical Trials and the NCI Cooperative Group Program
PIN: IOMX-H-08-06-A        

Major Unit:

Institute of Medicine

Sub Unit: Board on Health Care Services

RSO: Nass, Sharyl

Subject/Focus Area: Health and Medicine


Project Scope
An IOM committee will review the organization and operation of the National Cancer Institute (NCI) Cooperative Group Program and recommend ways to improve the quality of cancer clinical trials conducted by the Groups. Attention will be focused on how to improve, modernize and streamline the process, with special consideration given to the recent emphasis on targeted therapies due to an improved understanding of the biology of cancer. Given the limits on funding for cancer clinical trials, there is a particular need to improve efficiency and make efficient use of time, effort, and resources. Specifically, the committee will recommend ways to:
- Improve the design, review, and operation of clinical trials
- Reduce the prolonged period of time currently spent moving from initial concept to final approval
- Prioritize trials and trial sites based on scientific merit and past performance
- Increase participation of both clinicians and patients
- Make greater use of technologies such as imaging and biomarkers to select therapies for development and testing, to match patients and therapies, and to monitor patient responses
- Define standards for minimal data requirements to establish safety and efficacy of experimental therapies
- Reduce costs and ensuring adequate funds for high quality trials
- Promote greater collaboration among various stakeholders

SPONSORS:
- the Centers for Disease Control and Prevention (CDC)
- the Food and Drug Administration (FDA)
- the National Cancer Institute (NCI)
- the American Society of Clinical Oncology (ASCO)
- the Association of American Cancer Institutes (AACI)
- C-Change

The approximate starting date for the project is 12/01/2008.

A Final Report will be issued at the end of the project in approximately 16 months.

Project Duration: 16 Months.


 
Project Duration: 16 months    

Provide FEEDBACK on this project.

Contact the Public Access Records Office to make an inquiry, request a list of the public access file materials, or obtain a copy of the materials found in the file.


Committee Membership
Committee Membership

Meetings
 Meeting 1 - 12/16/2008
 Meeting 2 - 04/23/2009
 Meeting 3 - 07/22/2009
 Meeting 4 - 11/23/2009
 Meeting 5 - 01/05/2010
 Meeting 6 - 01/25/2010

Reports

Reports having no URL can be seen
at the Public Access Records Office


© Copyright 2010 The National Academies. All rights reserved. Tel: 202.334.2000 Fax: 202.334.1800 Email: info@nas.edu